Double-Blind, Cross-Over Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Ketamine (Primary) ; Naltrexone (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms Ket_Nal
- 20 Apr 2018 Status changed from recruiting to completed.
- 13 Jan 2017 New trial record